Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Song Zhou, Yu-ming Qiao, Yong-guang Liu, Ding Liu, Jian-min Hu, Jun Liao, Min Li, Ying Guo, Li-pei Fan, Liu-Yang Li, Ming Zhao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2020-11-01
Saila:Cell & Bioscience
Gaiak:
Acute kidney injury
Bone marrow derived mesenchymal stem cells
Erythropoietin
Lung entrapment
SIRT1
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s13578-020-00492-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak